Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are five patents protecting this drug. This drug has forty-eight…
The post New patent for Biocryst drug ORLADEYO appeared first on DrugPatentWatch - Make Better Decisions.